Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EBT (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of EBT data on record, last reported at -$5.9 million in Q3 2025.

  • For Q3 2025, EBT rose 77.82% year-over-year to -$5.9 million; the TTM value through Sep 2025 reached -$86.9 million, up 26.43%, while the annual FY2024 figure was -$120.5 million, 21.54% up from the prior year.
  • EBT reached -$5.9 million in Q3 2025 per FBIO's latest filing, up from -$35.9 million in the prior quarter.
  • Across five years, EBT topped out at -$5.9 million in Q3 2025 and bottomed at -$61.9 million in Q4 2021.
  • Average EBT over 5 years is -$37.5 million, with a median of -$35.9 million recorded in 2025.
  • Peak YoY movement for EBT: crashed 157.6% in 2021, then soared 78.97% in 2023.
  • A 5-year view of EBT shows it stood at -$61.9 million in 2021, then rose by 7.86% to -$57.0 million in 2022, then skyrocketed by 49.81% to -$28.6 million in 2023, then grew by 18.51% to -$23.3 million in 2024, then surged by 74.66% to -$5.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$5.9 million in Q3 2025, -$35.9 million in Q2 2025, and -$21.8 million in Q1 2025.